ArticleThe New England journal of medicine2023
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleThe New England journal of medicine2023
No numbers read from the abstract.